Adrenaline 150 micrograms auto-injectors supply: Urgent actions required by pharmacy teams

Further to previous announcements about the availability of EpiPen and EpiPen Junior, the Department of Health and Social Care (DHSC) and NHS England have asked all community pharmacies to implement an additional validation processes from tomorrow (Wednesday October 17th).

This has been put in place following critical supply issues to ensure that the limited stock of 150microgram (junior) adrenaline auto-injectors that will become available this week reaches those most in need.

DHSC has stated: “We have now reached a critical supply issue and need to implement controls on the supply of 150microgram adrenaline auto-injectors. Children weighing 25kg or less with the greatest short term need must have access to these first, ensuring that every patient has at least one in date 150microgram adrenaline auto injector. This can only be achieved by restricting issue of new devices until further notice.”

Pharmacy contractors and their teams are asked to read the NHS protocol and FAQs and to implement this new verification procedure with immediate effect on Wednesday October 17th.

Click here to read the NHS guidance